Intel is expanding its planned stock offering to $20 billion as the chipmaker steps up investments in artificial intelligence and semiconductor manufacturing, even as the move raises concerns about shareholder dilution.
The company said late Monday it increased the size of the offering from the initially announced $15 billion.
Intel plans to issue 210.5 million new shares priced at $95 each, representing a 2.6% discount to Monday’s closing price.
INTC stock fell 4.1% on Monday after the fundraising plan was announced and fell 0.62% on Tuesday.
Intel shares have surged more than 160% this year, helped by growing optimism around the company’s AI strategy and foundry ambitions.
However, the stock has declined 19% over the past three months.
Capital raise targets AI expansion and foundry growth
The expanded offering comes as Intel significantly increases spending on manufacturing capacity and AI-related infrastructure.
During its recent earnings call, management raised its 2026 capital expenditure forecast to more than $20 billion, up from approximately $18 billion, reflecting stronger demand for its products and long-term manufacturing strategy.
The proceeds from the stock sale are expected to support general corporate purposes, including continued investments in chip manufacturing and foundry operations.
“We see the raise as consistent with Intel funding an expansion to support current (increased CPU requirements) and future (custom ASIC, foundry, packaging) and demand,” wrote KeyBanc analyst Matt Bryson in a research note. “So, while the dilution is a negative for current investors, the demand signal is positive for Intel, its peers, and capital equipment suppliers.”
According to FactSet, Intel is expected to generate modestly negative free cash flow this year after posting cumulative negative free cash flow of $44 billion between 2022 and 2025.
Investors weigh dilution against long-term strategy
While the capital raise strengthens Intel’s financial flexibility, it also increases dilution for existing shareholders.
The issuance of 210.5 million shares represents roughly 4.9% dilution based on approximately 4.3 billion shares outstanding.
Underwriters also have a 30-day option to purchase an additional 31.6 million shares, potentially increasing dilution to around 5.6% if exercised.
Bloomberg reported that demand for the offering was multiple times oversubscribed, suggesting strong investor interest despite the discount.
Intel continues to invest heavily in its foundry business as it seeks to attract external customers to its 18A and future 14A manufacturing technologies.
The company is also making progress in advanced packaging technologies, with EMIB-T packaging reportedly achieving around 90% yields and targeting mass production in 2027.
Intel says the technology could deliver packaging at roughly half the cost of Taiwan Semiconductor Manufacturing Co.’s CoWoS-L platform.
The company is also advancing construction of its Ohio manufacturing campus, targeting full operations by 2031, while expanding opportunities to monetize its technology through licensing initiatives such as its Atom IP agreement with RosaicLabs.
The post Intel stock continues to fall as it expands stock sale to $20B appeared first on Invezz
